Works matching IS 2049-9450 AND VI 16 AND IP 4 AND DT 2022


Results: 20
    1
    2
    3
    4
    5

    Cancer cachexia as a determinant of efficacy of first-line pembrolizumab in patients with advanced non-small cell lung cancer.

    Published in:
    Molecular & Clinical Oncology, 2022, v. 16, n. 4, p. N.PAG, doi. 10.3892/mco.2022.2524
    By:
    • Fujii, Hironori;
    • Araki, Ayumu;
    • Iihara, Hirotoshi;
    • Kaito, Daizo;
    • Hirose, Chiemi;
    • Kinomura, Motohiko;
    • Yamazaki, Mizuki;
    • Endo, Junki;
    • Inui, Toshiya;
    • Yanase, Komei;
    • Sasaki, Yuka;
    • Gomyo, Takenobu;
    • Sakai, Chizuru;
    • Kawae, Daisuke;
    • Kitamura, Yu;
    • Fukui, Masachika;
    • Kobayashi, Ryo;
    • Ohno, Yasushi;
    • Suzuki, Akio
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20